About 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide
4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide (PubChem CID 22040332) has the molecular formula C29H31ClF3N7O2
and a molecular weight of 602.06 g/mol. Its IUPAC name is 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide.
Molecular Properties
| Compound Name | 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide |
| PubChem CID | 22040332 |
| Molecular Formula | C29H31ClF3N7O2 |
| Molecular Weight | 602.06 g/mol |
| Exact Mass | 601.22 |
| IUPAC Name | 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide |
| SMILES | CN1CCN(CCCNC(=O)c2cc(Oc3ccc4c(c3)nc(Nc3ccc(Cl)c(C(F)(F)F)c3)n4C)ccn2)CC1 |
| InChI | InChI=1S/C29H31ClF3N7O2/c1-38-12-14-40(15-13-38)11-3-9-35-27(41)25-18-21(8-10-34-25)42-20-5-7-26-24(17-20)37-28(39(26)2)36-19-4-6-23(30)22(16-19)29(31,32)33/h4-8,10,16-18H,3,9,11-15H2,1-2H3,(H,35,41)(H,36,37) |
| InChIKey | VDWYXBODCJQHFM-UHFFFAOYSA-N |
| XLogP | 5.54 |
| TPSA | 87.55 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 602.06 |
| LogP ≤ 5 | 5.54 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide?
The IUPAC name of 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide (CID 22040332) is 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide.
What is the SMILES notation for 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide?
The canonical SMILES for 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide is CN1CCN(CCCNC(=O)c2cc(Oc3ccc4c(c3)nc(Nc3ccc(Cl)c(C(F)(F)F)c3)n4C)ccn2)CC1.
What is the InChIKey of 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide?
The InChIKey is VDWYXBODCJQHFM-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H31ClF3N7O2/c1-38-12-14-40(15-13-38)11-3-9-35-27(41)25-18-21(8-10-34-25)42-20-5-7-26-24(17-20)37-28(39(26)2)36-19-4-6-23(30)22(16-19)29(31,32)33/h4-8,10,16-18H,3,9,11-15H2,1-2H3,(H,35,41)(H,36,37).
What are the key properties of 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide?
4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide has a molecular weight of 602.06 g/mol, XLogP of 5.54, 9 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-[4-chloro-3-(trifluoromethyl)anilino]-1-methylbenzimidazol-5-yl]oxy-N-[3-(4-methylpiperazin-1-yl)propyl]pyridine-2-carboxamide is sourced from PubChem (CID 22040332), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).